The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16–20 Weeks Gestation | Zendy

Miroslava Beňovská | Zendy; Aneta Opluštilová | Zendy; Jana Pinkavová | Zendy; Zuzana Hodická | Zendy; Zdeňka Čermáková | Zendy

Open Access

The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16–20 Weeks Gestation

Author(s) -

Miroslava Beňovská,

Aneta Opluštilová,

Jana Pinkavová,

Zuzana Hodická,

Zdeňka Čermáková

Publication year - 2017

Publication title -

laboratory medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.332

H-Index - 28

eISSN - 1943-7730

pISSN - 0007-5027

DOI - 10.1093/labmed/lmx076

Subject(s) - soluble fms like tyrosine kinase 1 , preeclampsia , placental growth factor , medicine , gestation , confidence interval , receiver operating characteristic , percentile , area under the curve , pregnancy , obstetrics , endocrinology , biology , vascular endothelial growth factor , statistics , mathematics , genetics , vegf receptors

Soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) are used in diagnosing preeclampsia (PE), but their potential in early prediction in pregnant women at 16 to 20 weeks gestation (WG) has remained unexplored.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research